Medicare Enrolled

Dr. Ekaterina Simakova, M.D.

Rheumatology · Jupiter, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1025 MILITARY TRL STE 209, Jupiter, FL 33458
5617471987
In practice since 2016 (10 years)
NPI: 1982066155 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simakova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simakova? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Simakova

Dr. Ekaterina Simakova is a rheumatology in Jupiter, FL, with 10 years in practice. Based on federal Medicare data, Dr. Simakova performed 81,157 Medicare services across 1,252 unique beneficiaries.

Between the years covered by Open Payments, Dr. Simakova received a total of $16,798 from 39 pharmaceutical and/or device companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Simakova is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 30% volume in FL$ $16,798 industry payments

Medicare Practice Summary

Medicare Utilization ↗
81,157
Medicare services
Top 30% in FL for rheumatology
1,252
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,116 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)35,400$4$11
Romosozumab injection (Evenity) for osteoporosis31,290$8$22
Denosumab injection (Prolia/Xgeva)5,940$18$42
Abatacept infusion (Orencia)4,425$30$76
Infliximab infusion (Remicade)1,880$26$73
Office visit, established patient (30-39 min)775$93$270
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle463$56$189
Administration of chemotherapy into vein, 1 hour or less158$103$345
New patient office visit (45-59 min)131$127$415
Injection, zoledronic acid, 1 mg65$5$16
X-ray of wrist, minimum of 3 views58$31$96
Joint injection, major joint57$41$175
X-ray of hand, minimum of 3 views57$28$77
Administration of chemotherapy into vein, each additional hour55$22$110
Aspiration and/or injection of fluid from small joint49$33$135
Betamethasone steroid injection46$4$12
Injection, methylprednisolone acetate, 40 mg45$5$30
Office visit, established patient, complex (40-54 min)44$135$364
Foot X-ray, 3+ views42$27$73
X-ray of ankle, minimum of 3 views40$29$75
Office visit, established patient (20-29 min)37$56$184
Injection, methylprednisolone acetate, 20 mg30$4$20
X-ray of lower and sacral spine, minimum of 4 views23$38$123
Shoulder X-ray, 2+ views20$28$73
Injection into tendon or ligament14$33$150
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less13$44$270
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.8% high complexity
90.7% medium
1.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,798
Total received (2019-2024)
Avg $2,800/year across 6 years
Top 29% in FL for rheumatology
39
Companies
629
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,375 (73.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,843 (22.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$320 (1.9%)
Scientific / Research
Research funding and grants
$260 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,242
2023
$3,463
2022
$4,941
2021
$1,927
2020
$125
2019
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$3,900
Amgen Inc.
$3,795
Mallinckrodt Hospital Products Inc.
$1,131
Novartis Pharmaceuticals Corporation
$1,021
UCB, Inc.
$853
GlaxoSmithKline, LLC.
$837
AbbVie Inc.
$635
Boehringer Ingelheim Pharmaceuticals, Inc.
$593
ANI Pharmaceuticals, Inc.
$534
ABBVIE INC.
$492
Horizon Therapeutics plc
$379
Aurinia Pharma U.S., Inc.
$352
PFIZER INC.
$303
Lilly USA, LLC
$267
Kyowa Kirin, Inc.
$238
Radius Health, Inc.
$173
Actelion Pharmaceuticals US, Inc.
$163
GENZYME CORPORATION
$151
Genentech USA, Inc.
$115
NeuroMetrix Inc
$100
SANOFI-AVENTIS U.S. LLC
$99
Ultragenyx Pharmaceutical Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$75
E.R. Squibb & Sons, L.L.C.
$74
Fresenius Kabi USA, LLC
$57
DePuy Synthes Sales Inc.
$45
Kiniksa Pharmaceuticals, Ltd.
$44
Kiniksa Pharmaceuticals International, plc
$43
SOBI, INC
$42
RECORDATI_RARE_DISEASES_INC.
$36
Organon LLC
$28
Abbott Laboratories
$23
Octapharma USA, Inc.
$22
Mylan Institutional Inc.
$22
Almatica Pharma LLC
$19
Exeltis, USA Inc.
$18
Alvogen Inc
$16
IDORSIA PHARMACEUTICALS US INC
$14
Organon Llc
$11
Top 3 companies account for 52.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · ETERNA · EVENITY · Enbrel · HADLIMA · HUMIRA · HYQVIA · Hulio · IDACIO · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · QUVIVIQ · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SKYRIZI · STELARA · SYLVANT · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $21 per 100 Medicare services performed
Looking for a rheumatology in Jupiter?
Compare rheumatologys in the Jupiter area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
25
Per 100K population
1.7
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Simakova is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Simakova experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Simakova performed 35,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simakova receive payments from pharmaceutical companies?
Yes. Dr. Simakova received a total of $16,798 from 39 companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simakova's costs compare to other rheumatologys in Jupiter?
Dr. Simakova's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simakova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →